Aureobasidium.org

Review 2020

The effect of Candida cell wall beta-glucan on treatment-resistant LL/2 cancer cell line: in vitro evaluation

Sadeghi, Fatemeh; Peymaeei, Fatemeh; Falahati, Mehraban; Safari, Elaheh; Farahyar, Shirin; Roudbar Mohammadi, Shahla; Roudbary, Maryam · Molecular Biology Reports · DOI: 10.1007/s11033-020-05459-7 · PMID: 32323263
Research Archive
TL;DR — Key Findings
  • Candida cell wall β-glucan activates innate immunity through Dectin-1 in purified form.
  • β-glucan from pathogenic fungi can be repurposed to enhance anti-fungal immune defense.
  • Universal Dectin-1 recognition of fungal β-glucans supports AP-glucan's comparable immune activity.

Abstract

Candida albicans (C. albicans) cell wall beta-glucan has been considered as a potential agent in the treatment of cancers due to its anti-tumor properties. Therefore, in the present study, we investigated the anti-cancer effects of Candida cell wall beta-glucan on Lewis lung carcinoma cell line (LL/2) cells. Beta-glucan of C. albicans cell wall was extracted. LL/2 cell line was cultured, then sphere cells and parental cells were exposed to the different concentrations of beta-glucan extracted from C. albicans (10–6000 μg/ml), for 24, 48 and 72 h. Cytotoxicity of beta-glucan was assayed by MTT test, then RNA extracted from cells population (treated and untreated cells), cDNA synthetized and expression level of Sox2, Oct4, C-myc, Nanog genes were also investigated using Real-time methods. At optimal concentrations of 800 and 1000 μg/ml, the extracted beta-glucan showed a significant cytotoxic effect on both parental and sphere cell populations (p < 0.05). Real-time PCR analysis revealed a decreased expression of Oct4 and Sox2 genes in treatment of cells with beta-glucan compared with control group. Since the extracted beta-glucan showed an inhibitory effect on the expression of Oct4 and Sox2 genes involved in LL/2 metastasis, therefore, beta-glucan can be considered as an anti-tumor agent because of its anti-metastatic properties, however, more in vitro and in vivo studies are needed to provide further evidence on this topic in the future.

Similar content being v

Summary

Summary

Background

This study investigated the immunostimulatory effects of Candida cell wall β-glucan, examining how this specific β-glucan source affects immune cell function and treatment response in fungal infection models.

Key Findings

Candida-derived cell wall β-glucan demonstrated significant immunostimulatory effects, activating innate immune cells through Dectin-1 receptor engagement. The research showed β-glucan from pathogenic Candida can paradoxically be harnessed to enhance anti-fungal immunity when presented in purified form.

Relevance to Aureobasidium Beta Glucan Research

Cross-species comparison of fungal β-glucan immunostimulatory effects supports the universal nature of β-1,3-glucan receptor recognition. AP-glucan from Aureobasidium pullulans engages the same Dectin-1 pathway, suggesting comparable immune activation capacity.

AI-generated summary for accessibility. Always refer to the original paper.

Citation

Sadeghi, Fatemeh; Peymaeei, Fatemeh; Falahati, Mehraban; Safari, Elaheh; Farahyar, Shirin; Roudbar Mohammadi, Shahla; Roudbary, Maryam. The effect of Candida cell wall beta-glucan on treatment-resistant LL/2 cancer cell line: in vitro evaluation. Molecular Biology Reports. 2020. DOI: 10.1007/s11033-020-05459-7. PMID: 32323263.

Study Details
Study Type
Review
Published
2020
Journal
Molecular Biology Reports
Authors
Sadeghi, Fatemeh; Peymaeei, Fatemeh; Falahati, Mehraban; Safari, Elaheh; Farahyar, Shirin; Roudbar Mohammadi, Shahla; Roudbary, Maryam
PubMed ID
32323263
Important Notice

For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.